Erenumab

Category: Migraine / Tension Headache



Erenumab Overview

Erenumab (trade name Aimovig) is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.[1][2][3] It was the first of the group of CGRPR antagonists to be approved in 2018.[4] Contents 1 Uses 2 Pharmacology 3 History 3.1 Development 3.2 Approval and marketing 4 See also 5 References Uses Erenumab is approved for prevention of migraine in adults.[5]...

Read more Erenumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Erenumab

Recent Erenumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Erenumab
  • Injection: 70mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Erenumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA